|
      
   
|
| |
Robert Franc
Director of Competitive Intelligence
Centocor
Over 26 years of Competitive Intelligence Experience;
12 years working for the US Government and 14 years in
the pharmaceutical industry. Has developed CI programs
in the US, Europe, Asia & the Middle East. During
his 14 years in the pharmaceutical industry, has supported
R&D and commercial organizations, both in the US & Europe.
Has spent the past 5 years as the Director for Competitive
Intelligence for Centocor, a biotechnology company in the
Johnson & Johnson pharmaceutical business. |
| |
|
 |
Craig McHenry
Senior Director, Competitor Insights
Wyeth
Craig joined Wyeth (formerly American
Home Products Corporation) in 1991 and advanced his understanding
of the pharmaceutical industry while working in several
business functions. He started in Global Business Development
and Licensing before moving to manage the Secondary Research
Analysis function. He has also worked in Marketing Research
where he spent two years directing oncology and hematology
market research in the Wyeth BioPharma business unit. Since
early in his career at Wyeth, Craig has been involved with
competitive intelligence. In 1993, Craig played a key role
in forming the first Business and Competitive Intelligence
function, which has evolved over the years into the current
group that he directs called Competitor Insights. One of
a handful of groups focused on specific analysis techniques,
this group provides CI consulting, expertise, and oversight
to brand teams, new product groups, and Senior Management.
Before Wyeth, Craig spent five years at Unisys and holds
a M.A. in Computer Science Ed. He has been a member of
SCIP since 1993 and is a graduate from the Gilead-Herring
Academy of Competitive Intelligence. |
| |
| |
Shacker Mourad, R.Ph, MBA
Director, Strategy Analysis and Intelligence
AstraZeneca, LP
Shacker is the Director of Competitive Intelligence for AstraZeneca US business.
Shacker’s 25 year pharmaceutical career spans the value chain in the US and abroad, where he worked in Quality Assurance for Eli Lilly International, Sales for Schering Plough, Sales and Marketing, Clinical Development and Intelligence for AstraZeneca and predecessor company AstraMerck.
He holds and MBA in Pharmaceutical Marketing from ST. Joseph’s University and holds Pharmacy Licenses in Pennsylvania and New York. He stays current with the Pharmacy profession by continuing to practice as an in-patient pharmacist in a hospital setting. |
| |
 |
Dr.
Daniel R. Pascheles
Vice President, Global Competitive Intelligence
Merck & Co., Inc.
Dr. Daniel R. Pascheles is Vice President,
Global Competitive Intelligence, and is based in Whitehouse
Station NJ, at the Global HQ of Merck & Co., Inc.
His responsibilities include providing
intelligence regarding business, research and development
activities of competitors, as well as participating in,
and contribution to the strategy development process, the
target identification for licensing and M&A activities.
Pascheles joined Merck & Co.,
Inc. early 2005 from Aventis Inc. where he was Vice President
and head of Corporate Competitive Intelligence. He has
worked for Aventis and its predecessor company (Hoechst
Marion Roussel, Marion Merrell Dow) for 14 years in various
positions and locations.
Pascheles studied Pharmacy at the
Swiss Federal Institute of Technology in Zurich, Switzerland.
He received his Ph.D. in Pharmaceutical Technology from
the same university. He has done additional study
at the University of Kansas in Lawrence, Kansas.
Pascheles is Past-President and current
Board member of the Pharmaceutical Business Intelligence & Research
Group (PBIRG). He is also member of the Society of Competitive
Intelligence Professionals (SCIP) and the Licensing Executive
Society (LES). |
| |
|
 |
Renee Pierson
Director of Business Intelligence
Ortho McNeil Pharmaceutical
Renee Pierson was recently appointed as Global Intelligence Leader, internal medicine & virology at Johnson & Johnson Pharmaceutical Services. Prior to this appointment, she was Director of Business Intelligence for Ortho-McNeil Janssen Pharmaceutical Services.
She joined the Johnson & Johnson Family of Companies in 1996 as a Manager, Marketing Research for New Products at Ortho-McNeil Pharmaceutical and has since moved to positions of increasing responsibility within the pharmaceutical sector at Johnson & Johnson. Prior to her appointment to Business Intelligence, she held the position of Group Director, Marketing Research & Forecasting.
Renee has over 20 years of experience in the Pharmaceutical Industry. In addition to Johnson & Johnson, she held positions at Novartis and Sanofi Aventis in areas of Finance, Business Planning and Market Research. She is past President and Board Member of the Pharmaceutical Marketing Research Group (PMRG) and has served on the Editorial Board for the Journal of Pharmaceutical Marketing & Management. Renee is also a member of the Society of Competitive Intelligence Professionals (SCIP).
She holds a Bachelor of Science in Marketing and Computer Systems and an MBA in Management from Fairleigh Dickinson University. She completed certification from the Academy of Competitive Intelligence. Additionally, Renee is certified in Health Care Compliance from Seton Hall Law School. |
| |
|
 |
Dawn Renear
Vice President, Competitive & Technical Information
Genzyme Corp.
Dawn Renear is Vice President of Competitive & Technical Information at Genzyme Corporation in Cambridge, MA. She oversees two intelligence functions: Technical Intelligence and Competitive & Market Intelligence. These groups are responsible for providing intelligence to all areas of the corporation, and are fully integrated into both business and science teams.
Dawn is responsible for integrating intelligence activities into business processes and growing corporation recognition of effective intelligence processes. Also under her responsibility is the Global Library group.
Prior to Genzyme, Dawn was Manager of Information Services at Integrated Genetics, Inc. and Analyst at the Center for the Analysis of Health Practices, Harvard School of Public Health. Dawn has over 25 years of experience in the biopharma industry. She holds a B.A. in Art History from the University of Massachusetts at Amherst and M.S. in Information Science from Simmons College.
|
| |
|
 |
Sue
Ward
Director, Information and Knowledge Management
Pfizer Global Research & Development
Sue Ward is currently Director of Competitive Intelligence
within Pfizer Global Research & Development. Before
working at Pfizer, Sue worked in the UK as Associate Director
of Competitive Analysis for SmithKline Beecham (SB) (now
GlaxoSmithKline). Other positions held within SB’s
R&D division included Manager of a Clinical Information
group and Manager of the Product Literature Information
Service. Sue holds a BSc (Hons) in Biology from
University College, London and an MSc in Information Science
from The City University, London. Sue is a member
of the Society of Competitive Intelligence Professionals
(SCIP). |
| |
|
| |
|
| |
|
| |
|
|
